Want to join the conversation?
$THC 2Q15 Call: Volume growth was strong and in line with expectations. EBITDA exceeded the high end of guidance even after excluding earnings of USPI and Aspen. Expects to generate approx. $1Bil in net cash proceeds from previously disclosed portfolio activities. Excluding earnings, delivered EBITDA of $552MM which exceeded guidance of $500-550MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.